C. Evan Ballantyne
2014 - Synthetic Biologics
In 2014, C. Evan Ballantyne earned a total compensation of $849.1K as Former Chief Financial Officer at Synthetic Biologics, a 116% increase compared to previous year.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Option Awards | $355,950 |
| Salary | $324,068 |
| Other | $19,085 |
| Total | $849,103 |
Ballantyne received $356K in option awards, accounting for 42% of the total pay in 2014.
Ballantyne also received $150K in bonus, $324.1K in salary and $19.1K in other compensation.
Rankings
In 2014, C. Evan Ballantyne's compensation ranked 8,282nd out of 13,032 executives tracked by ExecPay. In other words, Ballantyne earned more than 36.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,282 out of 13,032 | 36th |
Division Manufacturing | 3,072 out of 4,966 | 38th |
Major group Chemicals And Allied Products | 1,042 out of 1,686 | 38th |
Industry group Drugs | 821 out of 1,365 | 40th |
Industry Pharmaceutical Preparations | 636 out of 1,043 | 39th |
Source: SEC filing on July 6, 2016.
Ballantyne's colleagues
We found one more compensation record of an executive who worked with C. Evan Ballantyne at Synthetic Biologics in 2014.
2014
Jeffrey Riley
Synthetic Biologics